Construction and vaccine potential of acapsular mutants of Erysipelothrix rhusiopathiae: use of excision of Tn916 to inactivate a target gene.

Construction and vaccine potential of acapsular mutants of Erysipelothrix rhusiopathiae: use of excision of Tn916 to inactivate a target gene.

Item
http://www.wikidata.org/entity/Q33756359
Bacterial genome instabilityCapsular polysaccharide of Erysipelothrix rhusiopathiae, the causative agent of swine erysipelas, and its modification with phosphorylcholine.Serotyping of 800 strains of Erysipelothrix isolated from pigs affected with erysipelas and discrimination of attenuated live vaccine strain by genotyping.Immunological characterization of a protective antigen of Erysipelothrix rhusiopathiae: identification of the region responsible for protective immunityTruncated surface protective antigen (SpaA) of Erysipelothrix rhusiopathiae serotype 1a elicits protection against challenge with serotypes 1a and 2b in pigsThe capsule is a virulence determinant in the pathogenesis of Pasteurella multocida M1404 (B:2).Acapsular Pasteurella multocida B:2 can stimulate protective immunity against pasteurellosis.Erysipelothrix rhusiopathiae YS-1 as a live vaccine vehicle for heterologous protein expression and intranasal immunization of pigs.The genome of Erysipelothrix rhusiopathiae, the causative agent of swine erysipelas, reveals new insights into the evolution of firmicutes and the organism's intracellular adaptations.Immunostimulatory effects of recombinant Erysipelothrix rhusiopathiae expressing porcine interleukin-18 in mice and pigs.
P2860

Construction and vaccine potential of acapsular mutants of Erysipelothrix rhusiopathiae: use of excision of Tn916 to inactivate a target gene.

Item
http://www.wikidata.org/entity/Q33756359
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Construction and vaccine poten ...... 6 to inactivate a target gene.
@ast
Construction and vaccine poten ...... 6 to inactivate a target gene.
@en
type
label
Construction and vaccine poten ...... 6 to inactivate a target gene.
@ast
Construction and vaccine poten ...... 6 to inactivate a target gene.
@en
prefLabel
Construction and vaccine poten ...... 6 to inactivate a target gene.
@ast
Construction and vaccine poten ...... 6 to inactivate a target gene.
@en
P1433
P1476
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P932
P1433
P1476
Construction and vaccine poten ...... 16 to inactivate a target gene
@en
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P932